Skip to main content

Cocaine Use Disorder

6
Pipeline Programs
7
Companies
8
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Saniona
SanionaDenmark - Glostrup
1 program
1
NS2359Phase 21 trial
Active Trials
NCT02798627Completed55Est. Oct 2020
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
PsilocybinPhase 1/2
Biocorp
BiocorpFrance - Issoire
2 programs
2
Cohort 1 - TMP-301Phase 11 trial
TMP-301Phase 11 trial
Active Trials
NCT06025396Completed30Est. Jan 2024
NCT06648668Completed18Est. May 2025
Sandoz
SandozAustria - Kundl
1 program
1
AFQ056Phase 11 trial
Active Trials
NCT04771143Withdrawn0Est. Jan 2022
STALICLA
STALICLASwitzerland - Geneva
1 program
1
STP7Phase 11 trial
Active Trials
NCT06273540Completed21Est. Oct 2024
Soterix Medical
Soterix MedicalNJ - Woodbridge
3 programs
Soterix Medical mini-CT tDCS stimulatorN/A1 trial
Transcranial Direct Current StimulatorN/A1 trial
transcranial direct current stimulatorPHASE_21 trial
Active Trials
NCT03833583Completed25Est. Sep 2019
NCT07318480Recruiting120Est. Feb 2030
NCT04994821Completed60Est. Sep 2022
Tempero Bio
Tempero BioCA - Oakland
2 programs
Cohort 1 - TMP-301PHASE_1
TMP-301PHASE_1

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Soterix Medicaltranscranial direct current stimulator
SanionaNS2359
BiocorpTMP-301
STALICLASTP7
BiocorpCohort 1 - TMP-301
SandozAFQ056
Soterix MedicalTranscranial Direct Current Stimulator
Soterix MedicalSoterix Medical mini-CT tDCS stimulator

Clinical Trials (8)

Total enrollment: 329 patients across 8 trials

NCT04994821Soterix Medicaltranscranial direct current stimulator

TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study

Start: Sep 2020Est. completion: Sep 202260 patients
Phase 2Completed
NCT02798627SanionaNS2359

Trial Of NS2359 For The Treatment of Cocaine Dependence

Start: May 2016Est. completion: Oct 202055 patients
Phase 2Completed
NCT06648668BiocorpTMP-301

A Study to Investigate the Interaction Between TMP-301 and Cocaine.

Start: Jan 2025Est. completion: May 202518 patients
Phase 1Completed
NCT06273540STALICLASTP7

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Start: Apr 2024Est. completion: Oct 202421 patients
Phase 1Completed
NCT06025396BiocorpCohort 1 - TMP-301

Multiple Ascending Dose Study of TMP-301 in Healthy Subjects

Start: Jan 2023Est. completion: Jan 202430 patients
Phase 1Completed
NCT04771143SandozAFQ056

Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056

Start: Jul 2021Est. completion: Jan 20220
Phase 1Withdrawn
NCT07318480Soterix MedicalTranscranial Direct Current Stimulator

Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder

Start: Feb 2026Est. completion: Feb 2030120 patients
N/ARecruiting
NCT03833583Soterix MedicalSoterix Medical mini-CT tDCS stimulator

TDCS for Cocaine Addiction Craving

Start: Feb 2019Est. completion: Sep 201925 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 329 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.